Navigation Links
New mouse collaborative cross resource promises new cures and treatments for diseases
Date:2/16/2012

A new genetic resource from an international research consortium is expected to accelerate the development of new cures and treatments for a wide range of human diseases. This project, called the mouse "Collaborative Cross" (CC) resource, will increase the likelihood that experiments conducted in mice will advance our understanding of human biology. The mice in the CC have 90 percent of the genetic diversity present in laboratory mice, which mirrors the genetic diversity in humans. This will enable researchers to study traits and human diseases of complex origins in an appropriate model system.

Key findings arising from the CC will be published in February 2012 as a series of articles across both scientific journals published by the Genetics Society of America (GSA): GENETICS and G3: Genes|Genomes|Genetics. The 15 articles highlight the contributions of the CCand a companion mouse resource called the "Diversity Outbred" (DO) resourceto a number of important areas of human health. The MCC and DO are already shedding light on the genes influencing HDL cholesterol levels, systolic blood pressure, triglyceride levels, glucose, and variation in hematological traits like red and white blood cell counts, reactions to the influenza A virus, and mouse brain reaction to clozapine, a drug used for schizophrenia.

According to Dr. Fernando Pardo-Manuel de Villena (University of North Carolina at Chapel Hill Department of Genetics and Lineberger Comprehensive Cancer Center), one of the primary leaders of the CC, "A common complaint about using animal models has been the fact that some research doesn't carry over when applied to humans. The Collaborative Cross resource hopes to answer this complaint."

"Genetic causes may underlie many idiosyncratic adverse drug reactions," explained Dr. Gary Churchill (The Jackson Laboratory), another leader of the CC project. "Initial screening with this genetically diverse and heterogeneous model may allow for more realistic assessments of the risk of adverse effects and may be a reliable route for applying findings from mouse to human populations."

Dr. David Threadgill (North Carolina State University and UNC Lineberger), who originally proposed the idea for this resource and is also a leader of the project, added, "Research on mouse models may lead to increased safety in human drug trials and consequently has the potential of reducing the costs of drug development."

"Publishing these papers in GSA's sister journals enables those interested in this research to access a large body of information quickly and easily," said Dr. Lauren McIntyre, senior editor of the journal GENETICS and professor in the Department of Molecular Genetics and Microbiology at the University of Florida. "The journals have made all the data associated with the papers openly available, and are committed to the widest possible distribution. This group of research articles should help accelerate the development of new treatments and drugs."

The international consortium developing these mouse populations includes the University of North Carolina (UNC), North Carolina State University (NCSU), The Jackson Laboratory, Tel Aviv University, Oxford University and Geniad/Australia. The mice are housed and 'curated' at UNC-Chapel Hill. The CC and DO populations are available for researchers worldwide who need a common genetic reference population for the integrative analysis of complex systems.


'/>"/>
Contact: Phyllis Edelman
pedelman@genetics-gsa.org
301-634-7302
Genetics Society of America
Source:Eurekalert

Related biology news :

1. Sharp images from the living mouse brain
2. Multiple births lead to weight gain and other problems for mouse moms and male offspring
3. Severe congenital disorder successfully treated in a mouse model for the first time
4. Cleft lip corrected genetically in mouse model
5. Self-organized pituitary-like tissue from mouse ES cells
6. UCLA Engineering researchers help develop complete map of mouse genetic variation
7. Mouse genome sequences reveal variability, complex evolutionary history
8. A mouse model brings new perspectives on Lafora disease
9. Mouse virus erroneously linked to chronic fatigue syndrome, UCSF collaborative study finds
10. Of mice and men: UNC-led team solves mouse genome dilemma
11. What is a laboratory mouse? Jackson, UNC researchers reveal the details
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
Breaking Biology Technology: